Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infection

Digestion

Volumn 62, Issue 1, 2000, Pages 52-59

  Konrad, Thomas ^a   Zeuzem, S ^a   Toffolo, G ^c   Vicini, P ^b   Teuber, G ^a   Briem, D ^a   Lormann, J ^a   Lenz, T ^a   Herrmann, G ^a   Berger, A ^a   Cobelli, C ^c   Usadel, K H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b University of Washington   (United States)

^c Johann Wolfgang Goethe University ^*

Author keywords

Glucose tolerance; Hepatitis C; Insulin secretion; Insulin sensitivity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; GLUCOSE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER FIBROSIS; LIVER INJURY; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0033909854     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007778     Document Type: Article

References (42)

1. Gray H, Wreghitt T, Alexander GJM, Turner RC, O'Rahilly S: High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med 1995;12:244-249.
2. Özylikan E, Arslan M: Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1997;91:1480-1481.
3. Mason AL, Lau JYN, Hoang N, Qian K, Alexander GJM, Xu L, Guo L, Jacob S, Regenstein FG, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP: Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:328-333.
4. Grimbert S, Valensi P, Levy-Marchal C, Perret G, Richardet JP, Raffoux C, Trinchet JC, Beaugrand M: High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol 1996;20:544-548.
5. Knobler H, Stagnaro-Green A, Wallenstein S, Schwartz M, Roman SH: Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol 1998;26:30-33.
6. Fraser GM, Harman I, Meller N, Niv Y, Porath A: Diabetes mellitus is associated with chronic hepatitis C but not with chronic hepatitis B infection. Isr J Med Sci 1996;32:526-530.
7. Allison MED, Wreghitt T, Palmer CR, Alexander GJM: Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135-1139.
8. Simó R, Hernández C, Genescà J, Jard-R, Mesa J: High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996;19:998-1000.
9. Petrides AS: Liver disease and diabetes mellitus. Diabetes Rev 1994;2:2-18.
10. Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man. J Clin Invest 1981;68:1456-1467.
11. Henriksen JE, Alford F, Handberg A, Vaag A, Ward MG, Kalfas A, Beck-Nielsen H: Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1994;94:1196-1204.
12. Bogardus C, Lillioja S, Howard VB, Reaven GM, Mott D: Relationship between insulin secretion, insulin action, and lasting glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 1984;74:1238-1246.
13. Kruszynska YT, Harry DS, Bergman RN, McIntyre N: Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients. Diabetologia 1993;36:121-128.
14. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner SJ, Kahn RC: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study. Lancet 1992;340:925-929.
15. Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995;44:1386-1391.
16. Bergman RN, Ider ZY, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-E677.
17. Toffolo G, De Grandi F, Cobelli C: Estimation of β-cell sensitivity from intravenous glucose tolerance test C-peptide data. Diabetes 1995; 44:845-854.
18. Konrad T, Vicini P, Kusterer K, Höflich A, Assadkhani A, Böhles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel KH: α-Lipoic acid treatment descreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 1999;22:280-287.
19. Marchesini G, Pacini G, Bianchi G, Patrono D, Cobelli C: Glucose disposal, β-cell secretion, and hepatic insulin extraction in cirrhosis: A minimal model assessment. Gastroenterology 1990;99:1715-1722.
20. Kruszynska YT, Home PD, McIntyre N: Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology 1991;14:103-111.
21. Letiexhe MR, Scheen AJ, Gerard PL, Bastens BH, Pirotte J, Belaiche J, Lefèbvre PJ: Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. J Clin Endocrinol Metab 1993;77:1263-1268.
22. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435.
23. Zeuzem S, Schmidt JM, Lee JH, Rüster B, Roth K: Effect of interferon-α on the dynamics of hepatitis C virus turnover in vivo. Hepatology 1996;23:366-371.
24. Cerasi E, Luft R: The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol 1967;55: 278-304.
25. WHO Tech Rep Ser No 727: Diabetes mellitus. Geneva, WHO, 1985.
26. Rayfield EJ, Curnow RT, George DT, Beisel WR: Impaired carbohydrate metabolism during mild viral illness. N Engl J Med 1973;289: 618-621.
27. Sheth SG, Flamm SL, Gordon FD, Chopra S: AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998;93:44-48.
28. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, Hashimoto E, Lefkowitch JH, Ludwig J, Okuda K: The long-term pathological evolution of chronic hepatitis C. Hepalology 1996;23:1334-1340.
29. Wong VS, Wight DGD, Palmer RC, Alexander GJM: Fibrosis and other histological features in chronic hepatits C virus infection: A statistical model. J Clin Pathol 1996;49:465-469.
30. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward KW, Beard JC, Palmer JP, Porte D Jr: The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 1994;43:587-592.
31. Cobelli C, Pacini G, Toffolo G, Saccà L: Estimation of insulin sensitivity and glucose clearance from minimal model: New insights from labeled IVGTT. Am J Physiol 1986;250:E591-E598.
32. Luzi L, DeFronzo RA: Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol 1989;257:E241-E246.
33. Ader M, Ni TC, Bergman RN: Glucose effectiveness assessed under dynamic and steady-state conditions. J Clin Invest 1997;99:1187-1199.
34. 12 myotubes and in skeletal muscle. Diabetes 1995;44:646-651.
35. Goodyear LJ, Hirshman MF, Napoli R, Calles J, Markuns JF, Ljungqvist O, Horton ES: Glucose ingestion causes GLUT4 translocation in human skeletal muscle. Diabetes 1996;45: 1051-1056.
36. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM: The pathology of hepatits C. Hepatology 1992;15:567-571.
37. Magnusson J, Tranberg KG: Impaired early response to intravenous glucose in alcoholic liver cirrhosis. Scand J Gastroenterol 1987;22: 301-307.
38. Niederau C, Berger M, Stremmel W, Starke A, Strohmeyer G, Ebert R, Siegerl E, Creutzfeld W: Hyperinsulinaemia in non-cirrhotic haemochromatosis: Impaired hepatic insulin degradation? Diabetologia 1984;26:441-444.
39. McCullough AJ, Tavill AS: Disordered energy and protein metabolism in liver disease. Semin Liver Dis 1991;11:265-277.
40. Fabris C, Federico E, Soardo G, Falleti E, Pirisi M: Blood lipids of patients with chronic hepatitis: Differences related to viral etiology. Clin Chim Acta 1997;261:159-165.
41. Gurakar A, Fagiuoli S, Faruki H, De Maria N, Balkan M, Van Thiel DH, Friedlander L: Utility of hepatitis C virus RNA determination in hepatic tissue as an end point for interferon treatment of chronic hepatitis C. Hepatology 1995;22:1109-1112.
42. Strassburg CP, Obermayer-Straub P, Manns MP: Autoimmunity in hepatitis C and D virus infection. J Viral Hepat 1996;3:49-59.